complex stability in serum by agarose gel electrophoresis, lead carriers
(4–50, 6–40, 8–40, and 10–40) were formulated
as described above with OH-RNA labeled with AlexaFluor 647 (Integrated
DNA Technologies) at an N:P ratio of 20:1. Formulated fluorescent
OH-RNA/NPs were then supplemented with 10% additional PBS or to a
final concentration of 10% fetal bovine serum (FBS; Gibco) and incubated
at 37 °C for 0, 2, or 6 h prior to analysis by agarose gel (4%)
electrophoresis (1 μg RNA per lane). For the PBS group and t = 0 time point, the NPs and the respective diluent were
warmed to 37 °C and mixed immediately before loading. The gel
was subsequently imaged on a LICOR Odyssey imaging system. To evaluate
the effect of serum incubation on complex activity, lead carriers
were formulated with 3pRNA, diluted in 80% FBS for 0, 2, 6, 12, 18,
or 24 h, and activity evaluated in A549-Dual reporter cells (Invivogen)
as described above at a concentration of 2 nM RNA. Data are plotted
as a percentage of luminescence at t = 0 h after
subtracting background signal from vehicle (PBS) treated controls.